Document Detail

Protective effect of carteolol, a beta-blocker, on myocardial cellular damage in ischemic and reperfused pig hearts: assessment with gated in vivo 31-phosphorus magnetic resonance spectroscopy and electron microscopy.
MedLine Citation:
PMID:  1564729     Owner:  NLM     Status:  MEDLINE    
To assess the effect of carteolol, a beta-blocker, on ischemia and reperfusion, changes in the ultrastructure of myocytes and energy metabolism were studied by 31P-NMR in 41 pig hearts without collateral circulation. The left anterior descending coronary artery was occluded for 20 min and reperfused for 120 min in three groups: seven pigs (group 1, no treatment with carteolol; group 2, pre-ischemia treatment with carteolol (10 micrograms/kg); group 3, post-ischemia treatment with carteolol before reperfusion). Other groups of five pigs were killed after 120 min of ischemia (group 4, no treatment; group 5, pre-ischemia treatment) or 20 min of ischemia (group 6, no treatment; group 7, pre-ischemia treatment). After 20 min of ischemia, ATP was higher in groups 2 (76 +/- 9% of the baseline value) than in group 1 (59 +/- 5%) and group 3 (60 +/- 10%). However, the difference disappeared after 30 min of ischemia. After 120 min of reperfusion, ATP showed much better recovery in group 2 (92 +/- 9%) than in groups 1 (66 +/- 7%) and 3 (68 +/- 10%). Ischemic injury, as viewed by light and electron microscopy, was milder in group 7 than in group 6 after 20 min occlusion, but the myocytes were almost normal after 120 min reperfusion in groups 1 to 3. The heart rate, blood pressure and rate pressure product showed no significant difference among the groups. These results indicate that pre-ischemia treatment with carteolol provided protection against ischemic cellular injury and accelerated the repletion of ATP during reperfusion, but the post-ischemia treatment did not lead to recovery of ATP. Therefore, the favorable effect during reperfusion of pre-ischemia treatment with carteolol depends on its protective effect during ischemia.
M Ishida; H Fujiwara; M Kida; C Kawai; S Nakayama; S Yamashita; I Miura; Y Yabuuchi
Related Documents :
16126819 - Hypoxic reperfusion of the ischemic heart and oxygen radical generation.
11052279 - Effect of atp-potassium channel opener nicorandil on long-term cardiac preservation.
7509989 - Differential effects of endothelin-1 on normal and postischemic reperfused myocardium.
3919959 - Protective actions of propyl gallate, a lipoxygenase inhibitor, on the ischemic myocard...
10567329 - Opiate drugs and delta-receptor-mediated myocardial protection.
16557469 - Antiarrhythmogenic and antioxidant effect of the flavonoid dioclein in a model of cardi...
11827929 - Dynamic changes in three-dimensional architecture and vascular volume of transmural cor...
9469779 - Control of proximal hypertension during aortic cross-clamping: its effect on cerebrospi...
7327959 - Effect of systemic venous hypertension on pulmonary function and lung water.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of molecular and cellular cardiology     Volume:  24     ISSN:  0022-2828     ISO Abbreviation:  J. Mol. Cell. Cardiol.     Publication Date:  1992 Jan 
Date Detail:
Created Date:  1992-05-21     Completed Date:  1992-05-21     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0262322     Medline TA:  J Mol Cell Cardiol     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  21-34     Citation Subset:  IM    
Department of Internal Medicine, Kyoto University, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Adenosine Triphosphate / metabolism
Carteolol / therapeutic use*
Coronary Disease / pathology,  prevention & control*
Hydrogen-Ion Concentration
Magnetic Resonance Spectroscopy
Microscopy, Electron
Myocardial Reperfusion*
Myocardium / metabolism*,  ultrastructure
Phosphates / metabolism
Phosphocreatine / metabolism
Reg. No./Substance:
0/Phosphates; 51781-06-7/Carteolol; 56-65-5/Adenosine Triphosphate; 67-07-2/Phosphocreatine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  A cholesterol reduction demonstration project: results from a challenge between two cities.
Next Document:  Protection of energy status of hypoxic cardiomyocytes by mild acidosis.